Closing Remarks

Robert Lionberger, Ph.D., director, Office of Research and Standards in the Office of Generic Drugs at CDER provides closing remarks.

_______________________________ 
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.  
 
Phone - [phone] I [phone]